Clinical Trial Update: Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update on Omnitram for diabetic neuropathy, reporting safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Neuropathic Pain
• Pain

Drugs mentioned

• Omnitram

Snippet

Sponsor: Syntrix Biosystems, Inc. | Conditions: Diabetic Neuropathies, Neuropathic Pain | Phase 2 | Status: COMPLETED